Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 446,129 |
|
|||||
| News | - | ||||||
| Day High | 2.32 | Low High |
|||||
| Day Low | 2.16 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 1.79% | 2.27 | 18:11:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.20 | 2.16 | 2.32 | 2.27 | 2.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,147 | 446,129 | $ 2.26 | $ 1,006,621 | - | 1.08 - 3.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:27:51 | formt | 3,447 | $ 2.24 | USD |
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.5M | 20.22M | - | 0 | -30.04M | -1.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.30 | 2.90 | 2.16 | 2.48 | 654,980 | -0.03 | -1.30% |
| 1 Month | 2.6002 | 2.90 | 2.09 | 2.49 | 335,393 | -0.3302 | -12.70% |
| 3 Months | 1.61 | 3.78 | 1.32 | 2.38 | 3,384,632 | 0.66 | 40.99% |
| 6 Months | 1.42 | 3.78 | 1.08 | 2.37 | 1,599,502 | 0.85 | 59.86% |
| 1 Year | 1.40 | 3.78 | 1.08 | 2.35 | 809,261 | 0.87 | 62.14% |
| 3 Years | 0.91 | 3.78 | 0.1576 | 1.10 | 1,112,942 | 1.36 | 149.45% |
| 5 Years | 1.20 | 3.78 | 0.1576 | 1.13 | 1,127,764 | 1.07 | 89.17% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
